“I’m confident that in the decade ahead, we will be able to rebuild hearts and cure congenital heart disease with this technology. It is laborious work but a labor of love for our patients and their families.” Tim Nelson, MD, PhD
One Step Closer: HeartWorks Partners with SmartCella to Advance Cardiac Cell Delivery
Manufacturing personalized cardiac cells is one challenge. Getting them safely into the heart is another. HeartWorks has entered a licensing agreement with SmartCella, a Sweden-based biotech company, for its Extroducer® — a minimally invasive, catheter-based platform that could deliver cardiac cells directly to heart muscle without the need for open-heart surgery. Lab testing showed that our cardiac lineage cells maintained high viability through the delivery process, a key early milestone. Combined with reaching our first 100 biopsy participants, this partnership represents meaningful progress on the path to personalized CHD treatment.
